In summary, this study demonstrated that the Alzheimer’s genetic risk factor FERMT2 promotes the progression of CRC through Wnt/β-catenin signaling pathway and contributes to the inverse correlation between AD and CRC, which provides experimental foundation for further exploring the negative correlation mechanism between AD and cancers. Here, FERMT2 is linked to cancer.